Suitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 4.42 | 8.40 | 10.76 | -0.86 | 4.24 | 18.42 | 3.35 | -0.12 | -3.44 | 9.57 | 9.86 |
| S&P BSE Healthcare TRI | 0.95 | 8.95 | 11.16 | -3.17 | 0.78 | 13.24 | -4.68 | -3.16 | -5.47 | 8.06 | 10.40 |
| Equity: Sectoral-Pharma | 5.39 | 8.48 | 10.50 | -1.68 | 5.18 | 17.68 | 7.51 | 1.33 | -1.83 | 11.22 | 11.59 |
| Rank within category | 7 | 6 | 5 | 5 | 6 | 3 | 7 | 3 | 2 | 3 | 3 |
| Number of funds in category | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 4 | 3 | 3 | 3 |
As on 07-Apr-2020
| Best (Period) | Worst (Period) | |
|---|---|---|
| Week | 13.12 (14-Jun-2006 - 21-Jun-2006) | -16.12 (15-Jan-2008 - 22-Jan-2008) |
| Month | 18.81 (21-Jul-2006 - 21-Aug-2006) | -31.35 (09-May-2006 - 08-Jun-2006) |
| Quarter | 34.19 (09-Mar-2009 - 10-Jun-2009) | -27.70 (02-Sep-2008 - 03-Dec-2008) |
| Year | 99.77 (25-Mar-2009 - 25-Mar-2010) | -26.83 (31-Dec-2007 - 30-Dec-2008) |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| Fund | -2.50 | 15.77 | -0.51 | -0.82 | 0.84 | 1.09 |
| S&P BSE Healthcare TRI | -5.34 | 18.13 | -0.60 | -1.07 | -- | -- |
| Equity: Sectoral-Pharma | -0.97 | 15.89 | -0.40 | -0.64 | 0.83 | 2.57 |
| Rank within category | 3 | 3 | 3 | 3 | 3 | 3 |
| Number of funds in category | 4 | 4 | 4 | 4 | 4 | 4 |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on 31-Mar-2020
Please wait...
| Number of Stocks | 25 |
| Top 10 Stocks (%) | 61.23 |
| Top 5 Stocks (%) | 35.50 |
| Top 3 Sectors (%) | 98.14 |
| Portfolio P/B Ratio | 3.45 |
| Portfolio P/E Ratio | 26.67 |
| Fund | Category | |
|---|---|---|
| Average Mkt Cap (Rs Cr) | 22,649 | 22,876 |
| Giant (%) | -- | 1.78 |
| Large (%) | 29.81 | 37.31 |
| Mid (%) | 57.62 | 48.19 |
| Small (%) | 12.56 | 14.30 |
| Tiny (%) | -- | -- |
Please wait...
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 29-Feb-2020
— V Srivatsa since 02-Mar-2017
Education: Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.
Experience: Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.
Funds Managed:
Personal finance advice and mutual fund ideas delivered to your inbox every Monday
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
| Minimum Investment (₹) | 5,000 |
| Minimum Addl Investment (₹) | 1,000 |
| Minimum SIP Investment (₹) | 500 |
| Minimum No of Cheques | 6 |
| Minimum Withdrawal (₹) | -- |
| Minimum Balance (₹) | 5,000 |
| Exit Load | 1% for redemption within 364 days |
| Fund House: | UTI Mutual Fund |
| Launch Date: | 01-Aug-2005 |
| Return Since Launch: | 12.55% |
| Benchmark: | S&P BSE Healthcare TRI |
| Riskometer: | High |
| Type: | Open-ended |
| Assets: | ₹ 390 Cr (As on 29-Feb-2020) |
| Expense: | 2.53% (As on 29-Feb-2020) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | 45.00% |
| Plan | Record Date | Dividend (₹ / Unit) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | 28-Oct-2010 | 1.7000 | |||||||||||||||||
| |||||||||||||||||||
AMC: UTI Asset Management Company Ltd
Address: UTI Tower, 'GN' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051
Phone: 022- 66786666 / 66786354 / 1800-22-1230
Fax: 022-26523031
Email: [email protected]
Website: www.utimf.com
Registrar & Transfer Agent: KFin Technologies Pvt Ltd.
Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016
Phone: 040-44857874
Email: [email protected]
Website: www.karvymfs.com
Friday, 20-Mar-2020
12:30 PM - 01:00 PM
Registration Over
